Ruixuan Geng

773 total citations
29 papers, 556 citations indexed

About

Ruixuan Geng is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Ruixuan Geng has authored 29 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Ruixuan Geng's work include Lung Cancer Treatments and Mutations (6 papers), Gastric Cancer Management and Outcomes (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Ruixuan Geng is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Gastric Cancer Management and Outcomes (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Ruixuan Geng collaborates with scholars based in China, United States and Norway. Ruixuan Geng's co-authors include Jin Li, Jin Li, Congqi Dai, Jinjia Chang, Zheng Wu, Xinyang Liu, Xiaoxiao Ge, Rujiao Liu, Chenchen Wang and Wenbo Tang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Ruixuan Geng

26 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruixuan Geng China 12 254 234 196 148 66 29 556
Jianling Zou China 14 243 1.0× 200 0.9× 119 0.6× 122 0.8× 64 1.0× 18 467
Andrea Ravelli Italy 10 288 1.1× 200 0.9× 251 1.3× 106 0.7× 53 0.8× 15 543
Yuichi Hisamatsu Japan 15 277 1.1× 211 0.9× 194 1.0× 128 0.9× 45 0.7× 33 631
F. De Vita Italy 11 405 1.6× 198 0.8× 196 1.0× 220 1.5× 53 0.8× 37 691
Daniele Lavacchi Italy 12 303 1.2× 124 0.5× 184 0.9× 85 0.6× 37 0.6× 46 476
Elisa Giommoni Italy 14 314 1.2× 158 0.7× 180 0.9× 138 0.9× 52 0.8× 45 527
Xuelian Chen China 12 462 1.8× 218 0.9× 209 1.1× 163 1.1× 81 1.2× 36 779
Sai Ge China 12 215 0.8× 405 1.7× 164 0.8× 286 1.9× 34 0.5× 21 708
S.-A. Im South Korea 12 478 1.9× 93 0.4× 271 1.4× 159 1.1× 71 1.1× 39 686
Emanuela Dell’Aquila Italy 12 362 1.4× 171 0.7× 189 1.0× 242 1.6× 90 1.4× 41 593

Countries citing papers authored by Ruixuan Geng

Since Specialization
Citations

This map shows the geographic impact of Ruixuan Geng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruixuan Geng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruixuan Geng more than expected).

Fields of papers citing papers by Ruixuan Geng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruixuan Geng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruixuan Geng. The network helps show where Ruixuan Geng may publish in the future.

Co-authorship network of co-authors of Ruixuan Geng

This figure shows the co-authorship network connecting the top 25 collaborators of Ruixuan Geng. A scholar is included among the top collaborators of Ruixuan Geng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruixuan Geng. Ruixuan Geng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hong, Lingzhi, Sonia Patel, Leylah Drusbosky, et al.. (2024). Molecular landscape of ERBB2 alterations in 3000 advanced NSCLC patients. npj Precision Oncology. 8(1). 217–217. 11 indexed citations
3.
Geng, Ruixuan, et al.. (2023). Patients’ Preference for Physician Attire in the Internal Medicine Outpatient Department. BioMed Research International. 2023(1). 2992888–2992888. 4 indexed citations
4.
5.
Xiong, Yuanyuan, Tao Lu, Rongrong Chen, et al.. (2023). Genomic landscape and efficacy of HER2-targeted therapy in patients with HER2-mutant non-small cell lung cancer. Frontiers in Oncology. 13. 1121708–1121708. 5 indexed citations
6.
Zhao, Zihao, et al.. (2023). Design and Implementation of Geo-visualization of Human Mobility and Building Occupancy on Smart Campus. Abstracts of the ICA. 6. 1–2. 1 indexed citations
7.
Tang, Hui, Zhu Zhou, Tingting You, et al.. (2023). The prognostic role of WeChat-based instant doctor–patient communication in patients with advanced pancreatic cancer. Journal of Cancer Survivorship. 18(6). 1903–1911. 2 indexed citations
8.
9.
Li, Yanchen, Ruixuan Geng, Ke Zhao, et al.. (2023). Research progress of transcription factor FoxM1 in malignant tumors. Scientia Sinica Vitae. 53(9). 1239–1246. 2 indexed citations
10.
Zhao, Zihao, et al.. (2023). Geo-Visualization of Spatial Occupancy on Smart Campus Using Wi-Fi Connection Log Data. ISPRS International Journal of Geo-Information. 12(11). 455–455. 4 indexed citations
11.
Geng, Ruixuan, Zhibo Zheng, Yaguang Li, et al.. (2020). Clinical characteristics and prognostic factors of male yolk sac tumor: a Surveillance, Epidemiology, and End Results program study. World Journal of Urology. 39(4). 1211–1217. 9 indexed citations
12.
Zheng, Zhibo, Xingtong Zhou, Bangbo Zhao, et al.. (2020). Nomograms predict survival of patients with small bowel adenocarcinoma: a SEER-based study. International Journal of Clinical Oncology. 26(2). 387–398. 12 indexed citations
13.
He, Wan, et al.. (2019). Myeloid leukemia with high EVI1 expression is sensitive to 5-aza-2′-deoxycytidine by targeting miR-9. Clinical & Translational Oncology. 22(1). 137–143. 5 indexed citations
14.
Geng, Ruixuan, Li Song, Jin Li, & Lin Zhao. (2018). The safety of apatinib for the treatment of gastric cancer. Expert Opinion on Drug Safety. 17(11). 1145–1150. 48 indexed citations
15.
Dai, Congqi, Ruixuan Geng, Chenchen Wang, et al.. (2016). Concordance of immune checkpoints within tumor immune contexture and their prognostic significance in gastric cancer. Molecular Oncology. 10(10). 1551–1558. 53 indexed citations
16.
Liu, Rujiao, Xiaoying Zhao, Xin Liu, et al.. (2015). Influences of ERCC1, ERCC2, XRCC1, GSTP1, GSTT1, and MTHFR polymorphisms on clinical outcomes in gastric cancer patients treated with EOF chemotherapy. Tumor Biology. 37(2). 1753–1762. 11 indexed citations
17.
Zhang, Zhe, Jiping Wang, Dongmei Ji, et al.. (2014). Functional Genetic Approach Identifies MET, HER3, IGF1R, INSR Pathways as Determinants of Lapatinib Unresponsiveness in HER2-Positive Gastric Cancer. Clinical Cancer Research. 20(17). 4559–4573. 59 indexed citations
18.
Geng, Ruixuan & Jin Li. (2014). Apatinib for the treatment of gastric cancer. Expert Opinion on Pharmacotherapy. 16(1). 117–122. 78 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jianling Zou Breakdown of academic impact, for papers by Andrea Ravelli Breakdown of academic impact, for papers by Yuichi Hisamatsu Breakdown of academic impact, for papers by F. De Vita Breakdown of academic impact, for papers by Daniele Lavacchi Breakdown of academic impact, for papers by Elisa Giommoni Breakdown of academic impact, for papers by Xuelian Chen Breakdown of academic impact, for papers by Sai Ge Breakdown of academic impact, for papers by S.-A. Im Breakdown of academic impact, for papers by Emanuela Dell’Aquila
Rankless by CCL
2026